Botulinum Toxin Type A Neuromuscular Blockade in the Treatment of Equinus Foot Deformity in Cerebral Palsy: A Multicenter, Open-Label Clinical Trial von Koman, L. Andrew, Brashear, Allison, Rosenfeld, Samuel, Chambers, Henry, Russman, Barry, Rang, Mercer, Root, Leon, Ferrari, Eugenio, Garcia de Yebenes Prous, J, Smith, Beth P, Turkel, Catherine, Walcott, Jennifer M, Molloy, Patricia T

Volltext

Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial von de Yebenes, Justo Garcia, Dr, Landwehrmeyer, Bernhard, MD, Squitieri, Ferdinando, MD, Reilmann, Ralf, MD, Rosser, Anne, MD, Barker, Roger A, MD, Saft, Carsten, MD, Magnet, Markus K, MD, Sword, Alastair, MSc, Rembratt, Åsa, PhD, Tedroff, Joakim, MD

Volltext

Susceptibility to rotenone is increased in neurons from parkin null mice and is reduced by minocycline von Casarejos, M. J., Menéndez, J., Solano, R. M., Rodríguez‐Navarro, J. A., García de Yébenes, J., Mena, M. A.

Volltext

Searching for a prognostic index in lupus nephritis von Rodríguez-Almaraz, E, Gutiérrez-Solís, E, Rabadán, E, Rodríguez, P, Alonso, M, Carmona, L, de Yébenes, M J García, Morales, E, Galindo-Izquierdo, M

Volltext

L-DOPA-induced excessive daytime sleepiness in PD: A placebo-controlled case with MSLT assessment von GARCIA-BORREGUERO, D, SCHWARZ, C, LARROSA, O, DE LA LLAVE, Y, GARCIA DE YEBENES, J

Volltext

Effects of calcium antagonists on the dopamine system von MENA, M. A, GARCIA DE YEBENES, M. J, TABERNERO, C, CASAREJOS, M. J, PARDO, B, GARCIA DE YEBENES, J

Volltext

Progression of two Progressive Supranuclear Palsy phenotypes with comparable initial disability von Shoeibi, Ali, Litvan, Irene, Tolosa, Eduardo, Ser, Teodoro del, Lee, Euyhyun

Volltext

Acute Effects of 1‐Methyl‐4‐Phenyl‐1, 2, 3, 6‐Tetrahydropyridine in a Model of Rat Designated a Poor Metabolizer of Debrisoquine von Jiménez‐Jiménez, Félix Javier, Tabernero, César, Mena, María Angeles, García de Yébenes, Justo, Jesús García de Yébenes, María, Casarejos, María José, Pardo, Beatriz, García‐Agundez, José Augusto, Benítez, Julio, Martínez, Armando, García‐Asenjo, José Antonio López

Volltext

Differential effects of l‐DOPA on monoamine metabolism, cell survival and glutathione production in midbrain neuronal‐enriched cultures from parkin knockout and wild‐type mice... von Casarejos, M. J., Solano, R. M., Menéndez, J., Rodríguez‐Navarro, J. A., Correa, C., García de Yébenes, J., Mena, M. A.

Volltext

M07 Burden of Huntington's disease in Spain von Dorey, J, Trigo, P, Garcia de Yebenes, J, Toumi, M

Volltext

M07Burden of Huntington's disease in Spain von Dorey, J, Trigo, P, Garcia de Yebenes, J, Toumi, M

Volltext

L31 The Quality Of Life Of Spanish Patients With Huntington's Disease Measured With H-qol-i And Eq-5d von Hernandez, B., Trigo, P., Garcia de Yebenes, J., Clay, E., Toumi, M.

Volltext

L31The Quality Of Life Of Spanish Patients With Huntington's Disease Measured With H-qol-i And Eq-5d von Hernandez, B, Trigo, P, Garcia de Yebenes, J, Clay, E, Toumi, M

Volltext

A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy von Tolosa, Eduardo, Litvan, Irene, Höglinger, Günter U., Burn, David, Lees, Andrew, Andrés, María V., Gómez-Carrillo, Belén, León, Teresa, del Ser, Teodoro

Volltext

D07 Levels Of The Light Subunit Of Neurofilatment Protein In Cerebrospinal Fluid In Huntington's Disease von Lopez-Sendon, J., Picon, C., Garcia-Caldentey, J., Garcia de Yebenes, J., Alvarez-Cermeno, J., Villar, L.

Volltext

D07Levels Of The Light Subunit Of Neurofilatment Protein In Cerebrospinal Fluid In Huntington's Disease von Lopez-Sendon, J, Picon, C, Garcia-Caldentey, J, Garcia de Yebenes, J, Alvarez-Cermeno, J C, Villar, L M

Volltext

Adherence to biologic therapies and associated factors in rheumatoid arthritis, spondyloarthritis and psoriatic arthritis: a systematic literature review von López-González, Ruth, León, Leticia, Loza, Estibaliz, Redondo, Marta, Garcia de Yébenes, Maria Jesus, Carmona, Loreto

Volltext

Q07 Long-term safety and tolerability of pridopidine in patients with huntington's disease (HD): results of the mermaihd study open-label extension von Squitieri, F, Landwehrmeyer, B, Reilmann, R, Rosser, A, Garcia de Yebenes, J, Prang, A, Ivkovic, J

Volltext

Q07Long-term safety and tolerability of pridopidine in patients with huntington's disease (HD): results of the mermaihd study open-label extension von Squitieri, F, Landwehrmeyer, B, Reilmann, R, Rosser, A, Garcia de Yebenes, J, Prang, A, Ivkovic, J

Volltext

Effects of cinnarizine, a calcium antagonist that produces human parkinsonism, in parkin knock out mice von Serrano, A., Menéndez, J., Casarejos, M.J., Solano, R.M., Gallego, E., Sánchez, M., Mena, M.A., García de Yebenes, J.

Volltext